What’s Valeant ($VRX) Worth? IOI’s Quick Take on Damodaran’s Valuation

Erik Kobayashi-Solomon

November 27, 2016

A long-time reader of my work at Morningstar and IOI, Wilson M., wrote in over the Thanksgiving holiday to ask me what option strategy would be appropriate for an investor wanting to act on a recent valuation of Valeant Pharmaceuticals¬†(VRX) by Professor Aswath Damodaran, of New York University. My first step in structuring an investment …

Let's Chat

Use the form below to ask us any questions.


Current students can use this form to access our courses dashboard.

Not a student? Start a Free Trial!

Sign Up to View

Please enter your email to access to gain access to "What’s Valeant ($VRX) Worth? IOI’s Quick Take on Damodaran’s Valuation"

Contact Information

Know someone else who could benefit from Framework Investing industry leading investment research and investor training?